Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Toxicol (Phila) ; 55(2): 147-150, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27788591

RESUMEN

CONTEXT: Poisoning due to chloroform ingestion is rare. The classic features of acute chloroform toxicity include central nervous system (CNS) and respiratory depression, and delayed hepatotoxicity. CASE DETAILS: A 30-year-old female ingested 20-30 mL of 99% chloroform solution, which caused rapid loss of consciousness, transient hypotension and severe respiratory depression requiring endotracheal intubation and ventilation. She was alert by 12 h and extubated 16 h post-overdose. At 38-h post-ingestion, her liver function tests started to rise and she was commenced on intravenous acetylcysteine. Her alanine transaminase (1283 U/L), aspartate transaminase (734 U/L) and international normalized ratio (2.3) peaked 67- to 72-h post-ingestion. She also developed severe abdominal pain, vomiting and diarrhoea. An abdominal CT scan was consistent with severe enterocolitis, and an upper gastrointestinal endoscopy showed erosive oesophagitis, severe erosive gastritis and ulceration. She was treated with opioid analgesia, proton pump inhibitors, sucralfate and total parenteral nutrition. Secretions caused a contact dermatitis of her face and back. Nine days post-ingestion she was able to tolerate food. Her liver function tests normalized and the dermatitis resolved. Chloroform was measured using headspace gas chromatograph mass spectrometry, with a peak concentration of 2.00 µg/mL, 4 h 20 min post-ingestion. The concentration-time data fitted a 1-compartment model with elimination half-life 6.5 h. DISCUSSION: In addition to early CNS depression and delayed hepatotoxicity, we report severe gastrointestinal injury and dermatitis with chloroform ingestion. Recovery occurred with good supportive care, acetylcysteine and management of gastrointestinal complications.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Cloroformo/envenenamiento , Erupciones por Medicamentos/etiología , Enfermedades Gastrointestinales/inducido químicamente , Dolor Abdominal/inducido químicamente , Acetilcisteína/uso terapéutico , Adulto , Antídotos/uso terapéutico , Enfermedad Hepática Inducida por Sustancias y Drogas/fisiopatología , Enfermedad Hepática Inducida por Sustancias y Drogas/terapia , Cloroformo/farmacocinética , Erupciones por Medicamentos/patología , Erupciones por Medicamentos/terapia , Sobredosis de Droga , Femenino , Enfermedades Gastrointestinales/fisiopatología , Enfermedades Gastrointestinales/terapia , Semivida , Humanos , Pruebas de Función Hepática , Modelos Biológicos , Insuficiencia Respiratoria/inducido químicamente , Insuficiencia Respiratoria/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA